Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Thorac Surg. 2013 Aug;96(2):411-8. doi: 10.1016/j.athoracsur.2013.04.048. Epub 2013 Jun 24.

A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease.

Author information

  • 1Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California, USA.

Abstract

BACKGROUND:

Invasive lung adenocarcinomas increasingly present with synchronous, multifocal, in situ lesions that appear as ground glass opacities (GGOs). The optimal approach in this circumstance (often nonsmokers) remains unclear. We evaluated a general strategy of anatomic resection of the dominant tumor (DT) and wedge resection of accessible ipsilateral GGOs.

METHODS:

This is a retrospective review of 39 patients with suspected multifocal in situ adenocarcinomas and 1 DT in a predominantly Caucasian population. Mean follow-up is 30.7 months.

RESULTS:

Forty-nine percent of patients had no or minimal smoking history; 21% were Asian. The resected DT was pathologically "bronchioloalveolar carcinoma" (26%), minimally invasive adenocarcinoma (5%), adenocarcinoma with bronchioloalveolar features (41%), or moderate well-differentiated adenocarcinoma (28%). The p stage of the DT was IA in 20, IB in 15, and IIA in 4, with mean diameter of 2.6 cm. Thirty-two patients (82%) underwent anatomic resection of the DT; 7 (18%) underwent wedge resection. The mean number of GGOs present initially was 2.7 (range, 1 to 7) with a 5.2-mm mean diameter. An unresected nodule increased in size during follow-up in only 9 patients (23%). The mean diameter growth among these was 3.2 mm, with mean doubling time of 49 months. New GGOs (range, 1 to 8) developed in 16 patients (41%), all of which remained at 7 mm or less. Distant metastasis developed in 2 patients (5.2%); only 1 patient has required intervention for progression of a GGO. The overall survival is 100%.

CONCLUSIONS:

Patients with limited, multifocal, in situ adenocarcinomas and a clinical N0 DT enjoy prolonged survival with generally anatomic resection of the DT and wedge resection of accessible GGOs. These patients should not be considered to harbor T4 or M1a disease.

KEYWORDS:

10; AAH; AC; AIS; AJCC; American Joint Commission on Cancer; BAC; COPD; CT; DT; GGO; LPA; MIA; NSCLC; SBRT; SCC; SD; VATS; adenocarcinoma; adenocarcinoma in situ; atypical adenomatous hyperplasia; bronchioloalveolar carcinoma; chronic obstructive pulmonary disease; computed tomography; dominant tumor; ground glass opacity; lepidic predominant adenocarcinoma; minimally invasive adenocarcinoma; non-small cell lung carcinoma; squamous cell carcinoma; standard deviation; stereotactic body radiotherapy; video-assisted thoracoscopic surgery

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center